Enlicitide is an investigational synthetic peptide antagonist and GPR56 agonist designed to target the ghrelin receptor to regulate energy balance and suppress appetite in the management of obesity and… Read more
Enlicitide is an investigational synthetic peptide antagonist and GPR56 agonist designed to target the ghrelin receptor to regulate energy balance and suppress appetite in the management of obesity and metabolic disorders. To support rigorous analytical testing and quality control throughout the development lifecycle, this category offers essential research tools, including high-purity Enlicitide Chloride reference standards for structural characterization and method validation. Pharmaceutical laboratories also utilize stable isotope labelled compounds, such as Enlicitide-d9 Chloride, as internal standards in quantitative mass spectrometry assays. These labelled analogues provide the precise bioanalytical measurements necessary for accurate pharmacokinetic studies and metabolic profiling. By incorporating these high-quality materials into analytical workflows, researchers ensure the reliability of data when monitoring drug degradation, establishing impurity profiles, and confirming the identity of substances in complex biological matrices.